A detailed history of Citigroup Inc transactions in Twist Bioscience Corp stock. As of the latest transaction made, Citigroup Inc holds 50,459 shares of TWST stock, worth $2.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
50,459
Previous 27,138 85.93%
Holding current value
$2.1 Million
Previous $1.34 Million 70.46%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$36.72 - $58.88 $856,347 - $1.37 Million
23,321 Added 85.93%
50,459 $2.28 Million
Q2 2024

Aug 12, 2024

SELL
$27.95 - $53.0 $5.53 Million - $10.5 Million
-197,969 Reduced 87.94%
27,138 $1.34 Million
Q1 2024

May 10, 2024

BUY
$32.28 - $41.5 $4.12 Million - $5.3 Million
127,701 Added 131.1%
225,107 $7.72 Million
Q4 2023

Feb 09, 2024

SELL
$15.08 - $38.61 $2.52 Million - $6.44 Million
-166,798 Reduced 63.13%
97,406 $3.59 Million
Q3 2023

Nov 09, 2023

BUY
$18.62 - $26.57 $2.39 Million - $3.4 Million
128,098 Added 94.12%
264,204 $5.35 Million
Q2 2023

Aug 10, 2023

SELL
$11.49 - $20.46 $2.43 Million - $4.33 Million
-211,711 Reduced 60.87%
136,106 $2.78 Million
Q1 2023

May 11, 2023

BUY
$14.6 - $30.9 $2.9 Million - $6.14 Million
198,779 Added 133.37%
347,817 $5.25 Million
Q4 2022

Feb 09, 2023

BUY
$21.92 - $39.37 $25,449 - $45,708
1,161 Added 0.79%
149,038 $3.55 Million
Q3 2022

Nov 10, 2022

SELL
$33.44 - $56.56 $350,417 - $592,692
-10,479 Reduced 6.62%
147,877 $5.21 Million
Q2 2022

Aug 10, 2022

BUY
$26.2 - $54.0 $2.7 Million - $5.56 Million
102,984 Added 185.99%
158,356 $5.54 Million
Q1 2022

May 12, 2022

SELL
$38.58 - $83.27 $584,872 - $1.26 Million
-15,160 Reduced 21.49%
55,372 $2.73 Million
Q4 2021

Feb 10, 2022

BUY
$75.47 - $135.88 $2.79 Million - $5.02 Million
36,930 Added 109.9%
70,532 $5.46 Million
Q3 2021

Nov 10, 2021

BUY
$95.64 - $131.48 $3.21 Million - $4.42 Million
33,602 New
33,602 $3.59 Million

Others Institutions Holding TWST

About Twist Bioscience Corp


  • Ticker TWST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 56,363,500
  • Market Cap $2.35B
  • Description
  • Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...
More about TWST
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.